ホーム › 転移性癌 › テキサス

テキサスにおける転移性癌の臨床試験

テキサス内の拠点で、転移性癌に関する139件の研究が参加者を募集しています。

テキサス内の都市

公式研究テキスト（英語）

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Hendrick Medical Center, Abilene
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Lyndon Baines Johnson General Hospital, Houston
他2件

被験者募集中第2相

全年齢 · 全性別 · 2026/10/02更新 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

New Experimental Therapeutics - NEXT Oncology, Austin
Texas Oncology, Bedford
UT Southwest Simmons Cancer Center, Dallas
他2件

被験者募集中第1/2相

12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Texas Oncology - West Texas, Abilene
Texas Oncology - Austin, Austin
Texas Oncology - San Antonio, San Antonio
他1件

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

UT MD Anderson Cancer Center, Houston

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT05372614

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NEXT Austin, Austin
START Center for Clinical Research, Fort Worth
University of Texas MD Anderson Cancer Center, Houston
他1件

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Research Site, Houston

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/02更新 · NCT07205822

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Texas Oncology, Dallas
University of Texas Southwestern Medical Center, Dallas
University Medical Center & Texas Tech Health Science Center, Lubbock

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NEXT Oncology, Austin
UT Southwestern, Dallas

被験者募集中第1相

19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

MD Anderson Cancer Center, Houston
NEXT Oncology, San Antonio

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07213817

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

University of Texas - MD Anderson Cancer Center, Houston

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT05287945

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

SCRI at Mary Crowley, Dallas
University of Texas Southwestern Medical Center, Dallas
The University of Texas MD Anderson Cancer Center, Houston
他1件

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 5, Houston

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/30更新 · NCT07085091

A Study of ASP3082 in Adults With Advanced Solid Tumors

NEXT Oncology, San Antonio

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/30更新 · NCT05382559

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

University of Texas M.D. Anderson Cancer Center, Houston

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/29更新 · NCT05875168

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/29更新 · NCT06943755

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Texas Oncology - West Texas, Abilene
Texas Oncology - West Texas, Amarillo
Texas Oncology - Gulf Coast, Beaumont
他27件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

START Dallas Fort Worth, Fort Worth
MD Anderson, Houston
NEXT Oncology Houston, Houston
他1件

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413

Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis

M D Anderson Cancer Center, Houston

被験者募集中健康なボランティア歓迎

18歳以上 · 全性別 · 2026/09/25更新 · NCT05059678

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
Baylor College of Medicine, Houston

被験者募集中第1/2相

25歳以下 · 全性別 · 2026/09/25更新 · NCT04094610

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Texas Oncology - West Texas, Abilene
Texas Oncology - Northeast Texas, Allen
Texas Oncology - West Texas, Amarillo
他52件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
他3件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437